Laura Pace, NP
Nurse Practitioner · Fort Smith, ARNPI 1902300668
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by AbbVie at 41.3% of the total. Reporting peaked in 2022 at $335 and has fallen 95.4% since, to $15 in 2025.
Across 45 payments — averaging $13.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$258
- GSK$95
- Novo Nordisk$69
- Bayer$57
- Lilly USA, LLC$47
- Pfizer$45
- plus $55 from 2 others
What the payments were for
- Food & beverage$624100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 21 | $258 |
| GSK | 7 | $95 |
| Novo Nordisk | 4 | $69 |
| Bayer | 4 | $57 |
| Lilly USA, LLC | 3 | $47 |
| Pfizer | 3 | $45 |
| Biohaven Pharmaceuticals, Inc. | 2 | $30 |
| Amarin Pharma, Inc. | 1 | $25 |
How this compares
$624 in reported general payments places this provider in the 65th percentile of 697 nurse practitioner providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $362 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 21 | $270 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 35 | $200 |
| Mupirocin | 13 | $156 |
| Azithromycin | 37 | $148 |
| Triamcinolone Acetonide | 16 | $89 |
| Methylprednisolone | 11 | $68 |
| Amoxicillin | 18 | $60 |
| Prednisone | 52 | $57 |
| Meloxicam | 14 | $21 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Fort Smith
- Dakota YoungFort Smith$15K
- Kathleen MilamFort Smith$9K
- Lisa CokerFort Smith$8K
- Kathleen ToonFort Smith$7K
- Jenny HannaFort Smith$7K
- Jennifer JayFort Smith$6K
- Aida JonesFort Smith$5K
- Jacquelyn IsaacsFort Smith$4K
- Dana ReevesFort Smith$4K
- Merideth HanksRogers$157K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.